Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 6/2020

Ausgabe 6/2020

Inhaltsverzeichnis ( 14 Artikel )

10.10.2020 | Original Article | Ausgabe 6/2020

Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal function

Yanke Yu, Justin Hoffman, Anna Plotka, Melissa O’Gorman, Haihong Shi, Diane Wang

10.10.2020 | Original Article | Ausgabe 6/2020

Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation

Senthil Velan Bhoopalan, Shane J. Cross, John C. Panetta, Brandon M. Triplett

12.10.2020 | Original Article | Ausgabe 6/2020

Mass balance, metabolic disposition, and pharmacokinetics of [14C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration

Sufeng Zhou, Wei Liu, Chen Zhou, Lingling Zhang, Lijun Xie, Zhaoqiang Xu, Lu Wang, Yuqing Zhao, Lian Guo, Juan Chen, Lieming Ding, Li Mao, Yi Tao, Chen Zhang, Sijia Ding, Feng Shao

12.10.2020 | Original Article | Ausgabe 6/2020

The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis

Chen Ye, Abuduhaibaier Sadula, Siqian Ren, Xin Guo, Meng Yuan, Chunhui Yuan, Dianrong Xiu

14.10.2020 | Original Article | Ausgabe 6/2020 Open Access

Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors

Eryk Latoch, Katarzyna Konończuk, Katarzyna Taranta-Janusz, Katarzyna Muszyńska-Rosłan, Edyta Szymczak, Anna Wasilewska, Maryna Krawczuk-Rybak

16.10.2020 | Original Article | Ausgabe 6/2020

Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients

Mads Kingo Guldberg Hansen, Maja Patricia Smerdel, Marianne Waldstrøm, Rikke Fredslund Andersen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen

17.10.2020 | Original Article | Ausgabe 6/2020

Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer

Zhen Zhang, Luoyan Zhang, Guoxiang Yu, Zhigang Sun, Tiantian Wang, Xingsong Tian, Xuening Duan, Chi Zhang

19.10.2020 | Original Article | Ausgabe 6/2020

Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma

Xiang-Rong Ni, Cheng-Cheng Guo, Yan-Jiao Yu, Zhi-Hui Yu, Hai-Ping Cai, Wei-Chi Wu, Jun-Xiao Ma, Fu-Rong Chen, Jing Wang, Zhong-Ping Chen

21.10.2020 | Original Article | Ausgabe 6/2020 Open Access

The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo

Tangwu Zhong, Chuanke Zhao, Shuntao Wang, Deshuang Tao, Shuxia Ma, Chengchao Shou

21.10.2020 | Original Article | Ausgabe 6/2020

Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal®) in glioma patients in China

Chaoying Hu, Qingtang Lin, Chuan Liu, Jacqueline Liu, Xiaobao Chen, Xinxia Li, Guoguang Zhao, Lan Zhang

23.10.2020 | Original Article | Ausgabe 6/2020

Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma

Kojiro Hata, Kimitaka Suetsugu, Nobuaki Egashira, Yoko Makihara, Shinji Itoh, Tomoharu Yoshizumi, Masatake Tanaka, Motoyuki Kohjima, Hiroyuki Watanabe, Satohiro Masuda, Ichiro Ieiri

23.10.2020 | Original Article | Ausgabe 6/2020

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors

Khanh T. Do, Geraldine O’Sullivan Coyne, John L. Hays, Jeffrey G. Supko, Stephen V. Liu, Kristin Beebe, Len Neckers, Jane B. Trepel, Min-Jung Lee, Tomoko Smyth, Courtney Gannon, Jennifer Hedglin, Alona Muzikansky, Susana Campos, John Lyons, Percy Ivy, James H. Doroshow, Alice P. Chen, Geoffrey I. Shapiro

23.10.2020 | Clinical Trial Report | Ausgabe 6/2020

Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)

Emily Greengard, Yael P. Mosse, Xiaowei Liu, Charles G. Minard, Joel M. Reid, Stephan Voss, Keith Wilner, Elizabeth Fox, Frank Balis, Susan M. Blaney, Peter C. Adamson, Brenda J. Weigel

18.10.2020 | Short Communication | Ausgabe 6/2020

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

Maria Christina Cox, Marta Banchi, Sabrina Pelliccia, Arianna Di Napoli, Luigi Marcheselli, Caterina Patti, Paola Anticoli Borza, Roberta Battistini, Francesca Di Gregorio, Paola Orlandi, Guido Bocci

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise